Latest News & Updates
Breaking News
4 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Tonix Pharmaceuticals Publishes Phase 1 Data for Fc-Modified Anti-CD40L mAb TNX-1500 in Transplant Rejection
Tonix publishes Phase 1 data for Fc-modified anti-CD40L mAb TNX-1500; Phase 2 kidney transplant study at MGH targeted for H2 2026 pending FDA IND clearance.
Pharma Now Editorial Team
Atea Pharmaceuticals Achieves Favorable DDI Profile for BEM/RZR Fixed-Dose HCV Regimen in Phase 1
Atea's BEM/RZR HCV regimen shows clean DDI profile with omeprazole and rosuvastatin in Phase 1, with Phase 3 topline data pending.
Pharma Now Editorial Team
Jupiter Neurosciences Begins Enrollment in Phase 2a RESET Trial for Parkinson's Disease
Jupiter Neurosciences opens enrollment in Phase 2a RESET trial for JOTROL™, an investigational micellar resveratrol formulation targeting Parkinson's disease.
Pharma Now Editorial Team
3PBIOVIAN Adds Second 2,000 L Single-Use Bioreactor to Expand Mammalian Manufacturing Capacity
3PBIOVIAN commissions a second 2,000 L single-use bioreactor, extending its mammalian GMP platform from 50 L to commercial scale.
Pharma Now Editorial Team
